Therapy News and Research

RSS

Special Tree NeuroCare Center in Romulus offers greenhouse therapy

Recovering from a brain injury involves a great deal of hard work, and some of that work includes finding ways to enjoy life again.

4 Apr 2014

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

4 Apr 2014

Lifestyle interventions may help pre-diabetics dodge risk of death from cardiovascular disease

Many research studies have shown that lifestyle interventions, such as exercise programmes or weight loss, in people with impaired glucose tolerance (those at high risk of diabetes) can prevent progression to overt type 2 diabetes. However, until now, there has been a lack of high quality, randomized controlled trial evidence to prove that lifestyle interventions prevent deaths from cardiovascular disease, such as heart attacks and stroke, in these people.

4 Apr 2014

Novartis to present early stage data on 19 investigational compounds at AACR annual meeting

Novartis announced today that early stage data on 19 investigational compounds in its oncology pipeline will be presented at the annual meeting of the American Association of Cancer Research, April 5-9, 2014 in San Diego, CA.

4 Apr 2014

Researchers identify possible way to prevent headaches of climbers

By monitoring blood flow in the brains of six climbers scaling Mount Kilimanjaro in Tanzania, German medical researchers have identified a possible way to prevent the headaches that are a common feature of altitude sickness. This work appears in the latest issue of JNIRS—Journal of Near Infrared Spectroscopy.

4 Apr 2014

Study explores relationship between genetics and lifestyle in development of AD

A global study involving more than one million people worldwide will explore the relationship between genetics and lifestyle in the development of Alzheimer's disease.

4 Apr 2014

Researchers evaluate cost-effectiveness of osteoporosis screening strategy using FRAX

In new research presented at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases today, investigators showed that an osteoporosis screening strategy using FRAX as a pre-screening tool is cost-effective if the follow up of the screening and medication adherence are optimized.

4 Apr 2014

Alteration in tumor suppressor gene TP53 plays key role early in development of bone cancer

The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project found mutations in the tumor suppressor gene TP53 in 90 percent of osteosarcomas, suggesting the alteration plays a key role early in development of the bone cancer.

4 Apr 2014

Longer looks: New doubts about shaken baby syndrome; arresting the mentally ill; self-help therapy

A number of reexamined cases in recent years - aided by new technology and debate among medical experts - have put proponents of the (Shaken Baby Syndrome) hypothesis on the defensive.

4 Apr 2014

FDA approves expanded use Dyax’s KALBITOR in treatment of acute hereditary angioedema

Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.

4 Apr 2014

Cognitive dysfunction reflected in schizophrenia healthcare costs

Cognitive dysfunction has direct and indirect effects on healthcare costs in patients with schizophrenia, research suggests.

3 Apr 2014

Researchers examine risks and benefits of E-cigarettes

Some believe e-cigarettes are less harmful than smoking tobacco since e-cig vapor doesn't contain the chemicals found in tobacco smoke.

3 Apr 2014

Foundation Medicine, Clovis Oncology expand collaboration to develop novel companion diagnostic test

Foundation Medicine, Inc. and Clovis Oncology, Inc. today announced the expansion of their ongoing collaboration to incorporate a coordinated regulatory strategy for the development of a novel Premarket Approval (PMA) companion diagnostic test.

3 Apr 2014

Syneron's Sublative technology receives CE Mark for effective treatment of striae, acne scars

Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.

3 Apr 2014

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

CardioCell LLC has just received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with chronic heart failure (CHF), which generates more than 1 million hospitalizations annually.

3 Apr 2014

Patients' risk of stroke increases following shingles, but antiviral drugs appear to offer protection

Patients' risk of stroke significantly increased following the first signs of shingles, but antiviral drugs appeared to offer some protection, according to a new study in Clinical Infectious Diseases, now available online.

3 Apr 2014

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Gilead Sciences, Inc. today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in combination with ribavirin (RBV) for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.

3 Apr 2014

Therapy News and Research

Special Tree NeuroCare Center in Romulus offers greenhouse therapy

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Lifestyle interventions may help pre-diabetics dodge risk of death from cardiovascular disease

Novartis to present early stage data on 19 investigational compounds at AACR annual meeting

Researchers identify possible way to prevent headaches of climbers

Study explores relationship between genetics and lifestyle in development of AD

Researchers evaluate cost-effectiveness of osteoporosis screening strategy using FRAX

Alteration in tumor suppressor gene TP53 plays key role early in development of bone cancer

Longer looks: New doubts about shaken baby syndrome; arresting the mentally ill; self-help therapy

FDA approves expanded use Dyax’s KALBITOR in treatment of acute hereditary angioedema

Cognitive dysfunction reflected in schizophrenia healthcare costs

Researchers examine risks and benefits of E-cigarettes

Foundation Medicine, Clovis Oncology expand collaboration to develop novel companion diagnostic test

Syneron's Sublative technology receives CE Mark for effective treatment of striae, acne scars

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

Patients' risk of stroke increases following shingles, but antiviral drugs appear to offer protection

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Study looks at ability of nontoxic molecules to store harmful alpha emitting radioisotopes

Endurance sport keeps both muscles and nerves fit

Dartmouth aims to remove barriers for pancreatic cancer photodynamic therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News